As the U.S. stock market experiences a surge, driven by investor reactions to earnings reports and anticipation of tariff news, the focus remains on sectors like technology where chipmakers are ...

ImmunityBio, Inc. , a leading immunotherapy company, will announce new clinical findings for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in non-muscle invasive bladder cancer carcinoma in situ (NMIBC ...